SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Ralph W. who wrote (33632)10/9/1998 2:50:00 AM
From: Ralph W.  Read Replies (1) | Respond to of 132070
 
Mike - <OT> And on a more sober note have you checked out Andy Beyer's recent column in the Wash Post on the new drug replacing Lasix? Just another reason to keep me away. Bunch of guys suspended.
Ralph



To: Ralph W. who wrote (33632)10/9/1998 10:18:00 AM
From: Knighty Tin  Respond to of 132070
 
Ralph, Nope, but I remember the pe ratios on Biotech stocks in 1992. That was the last group where valuation didn't matter. Of course, now they've come down so much that I consider them value stocks. Alas, I considered some of them value stocks too soon. <G>

MB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News